SCHEMBL4886778

SCHEMBL4886778

CCOC(=O)c1cn2c3c(cc(F)cc3c1=O)OCC2

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 2/20 0.46
STAT3 P40763 2/20 0.42
KMT2A Q03164 3/20 0.41
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ADRB2 P07550 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
THRB P10828 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4887129 0.94 KDM4E (0.44) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL14529462 0.90 CYP1A2 (0.44) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL1431372 0.87 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL8908261 0.83 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL6413852 0.82 ALDH1A1 (0.44) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL11082542 0.82 STAT3 (0.51) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL4175922 0.81 KDM4E (0.42) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL11854230 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL30542740 0.76 STAT3 (0.49) KDM4EALDH1A1HPGDHSD17B10STAT3
SCHEMBL9749766 0.76 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10STAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096829-A1 Macrolone Compounds GLAXO GROUP LIMITED (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096829-A1 Macrolone Compounds MRPL21, MRPS18A, MRPL19 KDM4E 4136/4885ALDH1A1 3772/4885HPGD 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.